Lipinski’s Rule of Five, also known as Pfizer’s Rule of Five or simply the Rule of Five, is a valuable guideline in pharmaceutical research and drug development. It was developed by Christopher A. Lipinski in 1997 to assess the drug-likeness of chemical compounds, especially in terms of their suitability for oral administration in humans. This […]